Skip to main content
SAMIL PHARMACEUTICAL CO.,LTD logo

SAMIL PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 000520 ISIN · KR7000520007 KO Manufacturing
Open in API
Filings indexed 336 across all filing types
Latest filing 2020-04-17 Director's Dealing
Country KR South Korea
Listing KO 000520

About SAMIL PHARMACEUTICAL CO.,LTD

https://www.samil-pharm.com/main/EN

Samil Pharmaceutical Co., Ltd. is a company engaged in the research, development, and manufacturing of pharmaceutical products. The company specializes in ophthalmology and also produces a diverse portfolio of drugs for other therapeutic areas, including the central nervous system (CNS), hepatic conditions, and gastrointestinal disorders. Its product range encompasses prescription medicines as well as over-the-counter remedies for common ailments like fever and colds. In addition to developing its own products, Samil Pharmaceutical offers Contract Development and Manufacturing Organization (CDMO) services to global partners. The company emphasizes research and development and collaborates with other leading pharmaceutical firms.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by company insiders (directors/executives) to disclose their personal share transactions. This corresponds to the 'Director's Dealing' category, which covers insider trades and changes in share ownership by company management.
2020-04-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a regulatory filing from the South Korean financial market (DART system). The title '임원ㆍ주요주주 특정증권등 소유상황보고서' translates to 'Report on Ownership of Specific Securities by Executives and Major Shareholders'. This is a standard disclosure document for insider trading or changes in shareholdings by company directors and major shareholders, which corresponds to the 'Director's Dealing' category.
2020-04-17 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) filed by Samil Pharmaceutical. It details specific share purchases by company directors (Heo Seung-beom and Heo Jun-beom) and provides a comprehensive table of share ownership changes for major shareholders. This falls under the category of 'Major Shareholding Notification' (MRQ) as it reports changes in significant share ownership levels and insider holdings.
2020-04-13 Korean
사업보고서 (2019.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for Samil Pharmaceutical Co., Ltd. for the fiscal year 2019 (Jan 1, 2019 - Dec 31, 2019). It contains comprehensive sections including company overview, business description, financial statements, management discussion and analysis, and governance information. In the South Korean regulatory context, the 'Business Report' (사업보고서) is the equivalent of the US 10-K annual report, providing full-year financial performance and operational details. It is not an announcement or a summary, but the full report itself. FY 2019
2020-03-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when an insider (executive or major shareholder) changes their shareholding position. This corresponds to the 'Director's Dealing' category, which covers insider trades and changes in ownership by company directors and executives.
2020-03-24 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (AGM). It details the approval of financial statements, dividend declarations, and the election of directors and audit committee members. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2020-03-20 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.